Abstract:One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action. One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action.

Association of Renin BglI Polymphism with Essential Hypertension: a Meta-Analysis Involving 1811 Cases and 1626 Controls.

Association of Single Nucleotide Polymorphisms in ADIPOQ Gene with Risk of Hypertension: a Systematic Review and Meta-Analysis.

Association of Renalase Snps Rs2296545 and Rs2576178 with the Risk of Hypertension: A Meta-Analysis

Association of A-20C polymorphism in the angiotensinogen gene with essential hypertension: a meta-analysis.

PS 07-21 ASSOCIATION OF TWO SNPs rs2296545 AND rs2576178 IN RENALASE GENE WITH HYPERTENSION RISK: A META-ANALYSIS

Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses

Bradykinin Beta(2) Receptor-58t/C Gene Polymorphism And Essential Hypertension: A Meta-Analysis

Association Between Polymorphisms In The Renin-Angiotensin-Aldosterone System Genes And Essential Hypertension In The Han Chinese Population

Association Between Enos Rs1799983 Polymorphism and Hypertension: a Meta-Analysis Involving 14,185 Cases and 13,407 Controls

Association between the A46G polymorphism (rs1042713) in the 2-adrenergic receptor gene and essential hypertension susceptibility in the Chinese population A PRISMA-compliant meta-analysis

Association Between the A46G Polymorphism (rs1042713) in the Β2-Adrenergic Receptor Gene and Essential Hypertension Susceptibility in the Chinese Population

Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis.

Comprehensive Assessment of the Association of WNK4 Polymorphisms with Hypertension: Evidence from a Meta-Analysis

A46G and C79G polymorphisms in the β2-adrenergic receptor gene ( ADRB2 ) and essential hypertension risk: a meta-analysis

A46G AND C79G POLYMORPHISMS IN BETA2-ADRENERGIC RECEPTOR GENE (ADRB2) AND ESSENTIAL HYPERTENSION RISK: A META-ANALYSIS: PP.21.327

Association Of Polymorphisms In The Atrial Natriuretic Factor Gene With The Risk Of Essential Hypertension: A Systematic Review And Meta-Analysis

ACE2 Gene Polymorphism and Essential Hypertension: an Updated Meta-Analysis Involving 11,051 Subjects.

Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals

Association of Genetic Polymorphism of Β 2 - Bradykinin Receptor Gene and AGT Gene with Essential Hypertension in Shenzhen Population

Association Between Polymorphism Of The G-Protein Beta 3 Subunit C825t And Essential Hypertension: An Updated Meta-Analysis Involving 36,802 Subjects

Interleukin-6 Promoter −174G/C Polymorphism and Hypertension: A Case–control Study and a Meta-Analysis